vs
agilon health, inc.（AGL）与利氏兄弟拍卖行（RBA）财务数据对比。点击上方公司名可切换其他公司
agilon health, inc.的季度营收约是利氏兄弟拍卖行的1.3倍（$1.6B vs $1.2B），利氏兄弟拍卖行净利率更高（9.1% vs -12.0%，领先21.2%），利氏兄弟拍卖行同比增速更快（5.4% vs 3.1%），利氏兄弟拍卖行自由现金流更多（$186.5M vs $-23.5M），过去两年利氏兄弟拍卖行的营收复合增速更高（6.3% vs -1.1%）
agilon health是一家美国医疗保健企业，主要与基层医疗服务提供者合作，为联邦医疗保险覆盖的老年群体提供价值导向型医疗解决方案，为医生提供行政支持、临床工具及风险管理框架，在提升诊疗效果的同时降低医疗成本，业务覆盖美国20余个州。
利氏兄弟拍卖行（股票代码RBA）是全球知名的工业资产拍卖服务商，注册地位于加拿大，属公开上市企业，总部设在美国伊利诺伊州韦斯特切斯特，普通股同时在多伦多证券交易所与纽约证券交易所挂牌交易。
AGL vs RBA — 直观对比
营收规模更大
AGL
是对方的1.3倍
$1.2B
营收增速更快
RBA
高出2.3%
3.1%
净利率更高
RBA
高出21.2%
-12.0%
自由现金流更多
RBA
多$210.0M
$-23.5M
两年增速更快
RBA
近两年复合增速
-1.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.2B |
| 净利润 | $-188.9M | $109.7M |
| 毛利率 | — | — |
| 营业利润率 | -12.3% | 14.7% |
| 净利率 | -12.0% | 9.1% |
| 营收同比 | 3.1% | 5.4% |
| 净利润同比 | -78.5% | -7.4% |
| 每股收益（稀释后） | — | $0.53 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGLRBA
| Q4 25 | $1.6B | $1.2B | ||
| Q3 25 | $1.4B | $1.1B | ||
| Q2 25 | $1.4B | $1.2B | ||
| Q1 25 | $1.5B | $1.1B | ||
| Q4 24 | $1.5B | $1.1B | ||
| Q3 24 | $1.5B | $981.8M | ||
| Q2 24 | $1.5B | $1.1B | ||
| Q1 24 | $1.6B | $1.1B |
净利润AGLRBA
| Q4 25 | $-188.9M | $109.7M | ||
| Q3 25 | $-110.2M | $95.5M | ||
| Q2 25 | $-104.4M | $109.8M | ||
| Q1 25 | $12.1M | $113.4M | ||
| Q4 24 | $-105.8M | $118.5M | ||
| Q3 24 | $-117.6M | $76.1M | ||
| Q2 24 | $-30.7M | $111.1M | ||
| Q1 24 | $-6.1M | $107.4M |
营业利润率AGLRBA
| Q4 25 | -12.3% | 14.7% | ||
| Q3 25 | -9.1% | 14.5% | ||
| Q2 25 | -8.3% | 15.9% | ||
| Q1 25 | -1.4% | 17.1% | ||
| Q4 24 | -7.1% | 18.1% | ||
| Q3 24 | -9.2% | 15.6% | ||
| Q2 24 | -2.9% | 18.4% | ||
| Q1 24 | -0.4% | 18.7% |
净利率AGLRBA
| Q4 25 | -12.0% | 9.1% | ||
| Q3 25 | -7.7% | 8.7% | ||
| Q2 25 | -7.5% | 9.3% | ||
| Q1 25 | 0.8% | 10.2% | ||
| Q4 24 | -6.9% | 10.4% | ||
| Q3 24 | -8.1% | 7.8% | ||
| Q2 24 | -2.1% | 10.1% | ||
| Q1 24 | -0.4% | 10.1% |
每股收益（稀释后）AGLRBA
| Q4 25 | — | $0.53 | ||
| Q3 25 | — | $0.43 | ||
| Q2 25 | — | $0.53 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | — | $0.58 | ||
| Q3 24 | — | $0.36 | ||
| Q2 24 | — | $0.54 | ||
| Q1 24 | — | $0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $173.7M | $531.5M |
| 总债务越低越好 | $35.0M | $2.3B |
| 股东权益账面价值 | $126.7M | $5.6B |
| 总资产 | $1.3B | $12.1B |
| 负债/权益比越低杠杆越低 | 0.28× | 0.42× |
8季度趋势，按日历期对齐
现金及短期投资AGLRBA
| Q4 25 | $173.7M | $531.5M | ||
| Q3 25 | $171.7M | $674.7M | ||
| Q2 25 | $171.4M | $710.2M | ||
| Q1 25 | $136.9M | $578.1M | ||
| Q4 24 | $188.2M | $533.9M | ||
| Q3 24 | $148.2M | $650.7M | ||
| Q2 24 | $109.5M | $599.5M | ||
| Q1 24 | $111.7M | $462.8M |
总债务AGLRBA
| Q4 25 | $35.0M | $2.3B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | — | $2.6B | ||
| Q1 25 | — | $2.6B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | — | $2.8B | ||
| Q1 24 | — | $2.9B |
股东权益AGLRBA
| Q4 25 | $126.7M | $5.6B | ||
| Q3 25 | $306.1M | $5.5B | ||
| Q2 25 | $408.9M | $5.5B | ||
| Q1 25 | $500.3M | $5.3B | ||
| Q4 24 | $471.0M | $5.2B | ||
| Q3 24 | $574.9M | $5.2B | ||
| Q2 24 | $676.6M | $5.2B | ||
| Q1 24 | $689.3M | $5.1B |
总资产AGLRBA
| Q4 25 | $1.3B | $12.1B | ||
| Q3 25 | $1.6B | $12.2B | ||
| Q2 25 | $1.7B | $12.2B | ||
| Q1 25 | $1.9B | $11.9B | ||
| Q4 24 | $1.7B | $11.8B | ||
| Q3 24 | $2.1B | $11.9B | ||
| Q2 24 | $2.2B | $12.1B | ||
| Q1 24 | $2.3B | $12.0B |
负债/权益比AGLRBA
| Q4 25 | 0.28× | 0.42× | ||
| Q3 25 | — | 0.47× | ||
| Q2 25 | — | 0.47× | ||
| Q1 25 | — | 0.50× | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | 0.52× | ||
| Q2 24 | — | 0.55× | ||
| Q1 24 | — | 0.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.5M | $255.2M |
| 自由现金流经营现金流 - 资本支出 | $-23.5M | $186.5M |
| 自由现金流率自由现金流/营收 | -1.5% | 15.5% |
| 资本支出强度资本支出/营收 | 0.2% | 5.7% |
| 现金转化率经营现金流/净利润 | — | 2.33× |
| 过去12个月自由现金流最近4个季度 | $-119.0M | $719.2M |
8季度趋势，按日历期对齐
经营现金流AGLRBA
| Q4 25 | $-20.5M | $255.2M | ||
| Q3 25 | $-18.2M | $239.7M | ||
| Q2 25 | $-35.1M | $326.5M | ||
| Q1 25 | $-32.0M | $156.8M | ||
| Q4 24 | $16.4M | $184.5M | ||
| Q3 24 | $-7.7M | $285.4M | ||
| Q2 24 | $-18.7M | $337.3M | ||
| Q1 24 | $-47.8M | $124.8M |
自由现金流AGLRBA
| Q4 25 | $-23.5M | $186.5M | ||
| Q3 25 | $-21.3M | $188.5M | ||
| Q2 25 | $-38.3M | $241.7M | ||
| Q1 25 | $-35.8M | $102.5M | ||
| Q4 24 | $13.2M | $127.9M | ||
| Q3 24 | $-11.2M | $248.5M | ||
| Q2 24 | $-22.0M | $308.6M | ||
| Q1 24 | $-50.9M | $79.6M |
自由现金流率AGLRBA
| Q4 25 | -1.5% | 15.5% | ||
| Q3 25 | -1.5% | 17.3% | ||
| Q2 25 | -2.7% | 20.4% | ||
| Q1 25 | -2.3% | 9.2% | ||
| Q4 24 | 0.9% | 11.2% | ||
| Q3 24 | -0.8% | 25.3% | ||
| Q2 24 | -1.5% | 28.2% | ||
| Q1 24 | -3.2% | 7.5% |
资本支出强度AGLRBA
| Q4 25 | 0.2% | 5.7% | ||
| Q3 25 | 0.2% | 4.7% | ||
| Q2 25 | 0.2% | 7.2% | ||
| Q1 25 | 0.3% | 4.9% | ||
| Q4 24 | 0.2% | 5.0% | ||
| Q3 24 | 0.2% | 3.8% | ||
| Q2 24 | 0.2% | 2.6% | ||
| Q1 24 | 0.2% | 4.2% |
现金转化率AGLRBA
| Q4 25 | — | 2.33× | ||
| Q3 25 | — | 2.51× | ||
| Q2 25 | — | 2.97× | ||
| Q1 25 | -2.64× | 1.38× | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | — | 3.75× | ||
| Q2 24 | — | 3.04× | ||
| Q1 24 | — | 1.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGL
| Medical Services | $1.6B | 100% |
| Other Operating | $2.5M | 0% |
RBA
| Buyer Revenue | $577.2M | 48% |
| Seller Revenue | $255.2M | 21% |
| CA | $199.0M | 17% |
| Other | $124.7M | 10% |
| AU | $47.3M | 4% |
